Genome Medicine

Go back or start search again

General information ?

  • Published by: BioMed Central
  • ISSN: 1756-994X
  • Last checked date: 03/2020
  • Scope: Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
  • Additional free text: Co-submissions to other BMC ‘flagship’ journals. If a paper is potentially appropriate in scope for Genome Medicine and Genome Biology or BMC Biology authors have the opportunity to submit a manuscript for joint consideration at two of these journals at the same time. For a paper to be considered as a co-submission, authors should upload their manuscript to one of the two journals and note in their cover letter that they would like a co-consideration with the second journal. Each journal will evaluate the paper independently. If both journals decide to send the paper for review, the editors will select reviewers together for a peer review process that evaluates the manuscript for both journals, and will make independent decisions based on reviewers’ feedback.
  • Website
  • Instructions for authors


  • Main subject area: Medicine
  • Breadth of subject area: Top level subject
  • Peer review?

  • Peer review type: Conventional
  • Peer review openness: Closed, single blind
  • Selectivity: Selective (IF ~8-15)
  • Open access?

  • Free to read option: Paper can be free for anyone to read
  • Allows green OA: Not applicable as gold
  • Has waivers: Yes
  • Has membership system: Institutional membership
  • Access type: Full gold
  • Licence: All papers are CC BY
  • Level of APC: $2500-4500
  • Speed?

  • Speed to first decision: Unknown
  • Speed from acceptance to publication: Unknown
  • Other?

  • Ownership of publisher: Company
  • Length restrictions: None
  • Provides altmetrics: Altmetric
  • CrossMark implemented: Yes
  • Has a 2015 impact factor: Yes
  • Copyedits: Yes